A recent clinical trial involving dietary intervention low in AGEs, with predictive implications in breast cancer survivors, to reduce known (CRP and IL-6) and novel (AGE and RAGE) prognostic biomarkers, has been conducted in Washington University School of Medicine (WUSOM) [133]. Here, AGER is linked to breast cancer.